RedHill Biopharma reported $-4.22M in Operating Profit for its fiscal quarter ending in June of 2024.





Operating Profit Change Date
Clal Biotechnology ILS -1.74M 7.46M Dec/2022
Compugen USD -7.89M 540K Sep/2025
Cronos Group USD 55.24M 59.63M Sep/2025
RedHill Biopharma USD -4.22M 1.8M Jun/2024